Corcept Therapeutics Incorporated Stock Market Value
| CORT Stock | USD 69.00 1.83 2.72% |
| Symbol | Corcept |
Corcept Therapeutics Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Corcept Therapeutics. If investors know Corcept will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Corcept Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.09) | Earnings Share 1.12 | Revenue Per Share | Quarterly Revenue Growth 0.187 | Return On Assets |
The market value of Corcept Therapeutics is measured differently than its book value, which is the value of Corcept that is recorded on the company's balance sheet. Investors also form their own opinion of Corcept Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Corcept Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Corcept Therapeutics' market value can be influenced by many factors that don't directly affect Corcept Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Corcept Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Corcept Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Corcept Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Corcept Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Corcept Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Corcept Therapeutics.
| 05/06/2025 |
| 08/04/2025 |
If you would invest 0.00 in Corcept Therapeutics on May 6, 2025 and sell it all today you would earn a total of 0.00 from holding Corcept Therapeutics Incorporated or generate 0.0% return on investment in Corcept Therapeutics over 90 days. Corcept Therapeutics is related to or competes with Crinetics Pharmaceuticals, Enanta Pharmaceuticals, Amicus Therapeutics, Connect Biopharma, Cytokinetics, Supernus Pharmaceuticals, and Vanda Pharmaceuticals. Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, o... More
Corcept Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Corcept Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Corcept Therapeutics Incorporated upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 11.14 | |||
| Value At Risk | (4.33) | |||
| Potential Upside | 3.42 |
Corcept Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Corcept Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Corcept Therapeutics' standard deviation. In reality, there are many statistical measures that can use Corcept Therapeutics historical prices to predict the future Corcept Therapeutics' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.39) | |||
| Treynor Ratio | (0.09) |
Corcept Therapeutics Backtested Returns
Corcept Therapeutics secures Sharpe Ratio (or Efficiency) of close to zero, which signifies that the company had a close to zero % return per unit of risk over the last 3 months. Corcept Therapeutics Incorporated exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Corcept Therapeutics' Standard Deviation of 2.41, mean deviation of 1.84, and Risk Adjusted Performance of (0.01) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.77, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Corcept Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Corcept Therapeutics is expected to be smaller as well. At this point, Corcept Therapeutics has a negative expected return of -0.0117%. Please make sure to confirm Corcept Therapeutics' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to decide if Corcept Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.10 |
Insignificant predictability
Corcept Therapeutics Incorporated has insignificant predictability. Overlapping area represents the amount of predictability between Corcept Therapeutics time series from 6th of May 2025 to 20th of June 2025 and 20th of June 2025 to 4th of August 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Corcept Therapeutics price movement. The serial correlation of 0.1 indicates that less than 10.0% of current Corcept Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.1 | |
| Spearman Rank Test | -0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 5.72 |
Corcept Therapeutics lagged returns against current returns
Autocorrelation, which is Corcept Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Corcept Therapeutics' stock expected returns. We can calculate the autocorrelation of Corcept Therapeutics returns to help us make a trade decision. For example, suppose you find that Corcept Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Corcept Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Corcept Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Corcept Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Corcept Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Corcept Therapeutics Lagged Returns
When evaluating Corcept Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Corcept Therapeutics stock have on its future price. Corcept Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Corcept Therapeutics autocorrelation shows the relationship between Corcept Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Corcept Therapeutics Incorporated.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Corcept Stock Analysis
When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.